Novo Nordisk A/S (NYSE:NVO) ranks among the best set-it-and-forget-it stocks to buy. Novo Nordisk A/S (NYSE:NVO) announced on ...

Weight Watchers is Novo Nordisk's latest partnersip.

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.

GE to spend $490 million on Kentucky plant; Weight Watchers partners with Novo Nordisk to sell Wegovy; TSA warns: Waffle ...

Under the deal, cash-paying patients can access a month’s supply of Wegovy through the Danish drugmaker’s Novocare pharmacy for $299. The one-time price will also be available through Novo’s other ...

MHRA launches genetic study into GLP-1 drug risks as Spain investigates Novo Nordisk for potential advertising violations.

Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.

Glanbia is navigating headwinds in performance nutrition and SlimFast, with fair valuation and mixed outlook despite solid ...

STORY: Novo Nordisk is to collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy.Under the deal to ...